Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A Net Tangible Assets

Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A (FBIOP) currently reports a net tangible assets of $200M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A's net tangible assets history and peer comparisons.

Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A's net tangible assets changed from $0 to $200M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A reported $200M in net tangible assets as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $200M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A, and consider following FBIOP for alerts when major investors trade the stock.

Fortress Biotech- 9.375% PRF PERPETUAL USD 25 - Ser A is classified in the Healthcare sector. On net tangible assets, it currently shows $200M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FBIOP with unrelated industries.